RecruitingPhase 2NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Sponsor: Artiva Biotherapeutics, Inc.
Arlington, TX · Bellaire, TX · Irving, TX · +28 more sites